Literature DB >> 16247765

Increased expression of calcium/calmodulin-dependent protein kinase IIbeta in frontal cortex in schizophrenia and depression.

G Novak1, P Seeman, T Tallerico.   

Abstract

In searching for genes dysregulated in schizophrenia, we measured the expression of the two splice variants of calcium/calmodulin-dependent protein kinase II (CaMKIIalpha and CaMKIIbeta) in postmortem frontal cerebral cortex tissues from patients who had died with schizophrenia, bipolar disorder, or severe depression. The mRNA levels of expression of these two splice variants were measured by real-time Quantitative PCR, using an Mx4000 instrument. The values for the expression of CaMKIIalpha and CaMKIIbeta were normalized by the expression of beta-glucuronidase in the tissues. The expression of CaMKIIalpha was significantly elevated in the depression tissues by 29%. The expression of CaMKIIbeta was significantly elevated in the schizophrenia tissues by 27%, and in the depression tissues by 36%. Because CaMKIIbeta influences the expression of many neuroreceptors and influences neural outgrowth and pruning, its altered expression in the cerebral cortex in schizophrenia or depression may contribute to these diseases. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16247765     DOI: 10.1002/syn.20211

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  29 in total

1.  βCaMKII in lateral habenula mediates core symptoms of depression.

Authors:  Kun Li; Tao Zhou; Lujian Liao; Zhongfei Yang; Catherine Wong; Fritz Henn; Roberto Malinow; John R Yates; Hailan Hu
Journal:  Science       Date:  2013-08-30       Impact factor: 47.728

2.  Altered expression of neuroplasticity-related genes in the brain of depressed suicides.

Authors:  B Fuchsova; A Alvarez Juliá; H S Rizavi; A C Frasch; G N Pandey
Journal:  Neuroscience       Date:  2015-04-28       Impact factor: 3.590

3.  Gene expression in major depressive disorder.

Authors:  R Jansen; B W J H Penninx; V Madar; K Xia; Y Milaneschi; J J Hottenga; A R Hammerschlag; A Beekman; N van der Wee; J H Smit; A I Brooks; J Tischfield; D Posthuma; R Schoevers; G van Grootheest; G Willemsen; E J de Geus; D I Boomsma; F A Wright; F Zou; W Sun; P F Sullivan
Journal:  Mol Psychiatry       Date:  2015-05-26       Impact factor: 15.992

4.  Association of ADAM10 and CAMK2A polymorphisms with conduct disorder: evidence from family-based studies.

Authors:  Xue-Qiu Jian; Ke-Sheng Wang; Tie-Jian Wu; Joel J Hillhouse; Jerald E Mullersman
Journal:  J Abnorm Child Psychol       Date:  2011-08

Review 5.  Early reproductive experiences in females make differences in cognitive function later in life.

Authors:  Rena Li; Jie Cui; Balaji Jothishankar; Juliet Shen; Ping He; Yong Shen
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

6.  HIV and SIV induce alterations in CNS CaMKII expression and activation: a potential mechanism for cognitive impairment.

Authors:  Ravi G Gupta; Kathleen M Kelly; Kris L Helke; Suzanne E Queen; Jami M Karper; Jamie L Dorsey; Angela K Brice; Robert J Adams; Patrick M Tarwater; Dennis L Kolson; Joseph L Mankowski
Journal:  Am J Pathol       Date:  2010-04-09       Impact factor: 4.307

7.  Dopamine D4 receptor transmission in the prefrontal cortex controls the salience of emotional memory via modulation of calcium calmodulin-dependent kinase II.

Authors:  Nicole M Lauzon; Tasha Ahmad; Steven R Laviolette
Journal:  Cereb Cortex       Date:  2011-11-24       Impact factor: 5.357

8.  A genetic variant in CAMKK2 gene is possibly associated with increased risk of bipolar disorder.

Authors:  Minoo Atakhorrami; Simin Rahimi-Aliabadi; Javad Jamshidi; Elham Moslemi; Abolfazl Movafagh; Mina Ohadi; Arash Mirabzadeh; Babak Emamalizadeh; Hamid Ghaedi; Fatemeh Gholipour; Atena Fazeli; Marzieh Motallebi; Shaghayegh Taghavi; Azadeh Ahmadifard; Saeed Mohammadihosseinabad; Amir Ehtesham Shafiei Zarneh; Neda Shahmohammadibeni; Faranak Madadi; Monavvar Andarva; Hossein Darvish
Journal:  J Neural Transm (Vienna)       Date:  2015-09-09       Impact factor: 3.575

Review 9.  Molecular mechanisms underlying synergistic effects of SSRI-antipsychotic augmentation in treatment of negative symptoms in schizophrenia.

Authors:  Yael Chertkow; Orly Weinreb; Moussa B H Youdim; Henry Silver
Journal:  J Neural Transm (Vienna)       Date:  2009-07-04       Impact factor: 3.575

10.  A postpartum model in rat: behavioral and gene expression changes induced by ovarian steroid deprivation.

Authors:  Shiro Suda; Eri Segi-Nishida; Samuel S Newton; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2008-05-08       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.